Zhou Ying
Chief Pharmacist, Associate Professor, Graduate Supervisor
Research Interests: drug development, clinical pharmacy, clinical pharmacology
Tel: 010-83575892, 18610710321
Email: zhouying0321@126.com
EDUCATION
Doctor of Science, Peking University (2025)
Master of Science, Peking University (2006)
Bachelor of Science, Peking University Health Science Center (1994)
PROFESSIONAL EXPERIENCE
1994 - present Peking University First Hospital
Pharmacist (1994), Pharmacist-in-charge (1999), Associate Chief Pharmacist (2005), Chief Pharmacist (2010)
Master Supervisor (2005), Associate Professor (2020)
Joint Party Branch Secretary for Pharmacy Department/Drug Clinical Trial Institution (2024)
2011 - present Peking University First Hospital, Pharmacy Department
Deputy Director of Pharmacy Department (2011), Director of Pharmacy Department (2023)
2023 - present Peking University First Hospital, Drug Clinical Trial Institution
Deputy Director of Pharmacy Department (2023)
2004.12 – 2005.2 University of Toyama
Visiting Scholar
ACADEMIC APPOINTMENTS
International Pharmaceutical Federation (FIP) Chronic Diseases Working Group, Member
Rare Disease Alliance, Clinical Pharmacology Research and Application Branch for Rare Disease Drugs, Chair
Chinese Pharmaceutical Association, Rare Disease Drug Professional Committee, Deputy Director
China Health Care Association for the Elderly, Pharmaceutical Media Promotion Working Committee, Director
Beijing Medical Doctor Association, Drug Research and Translation Branch, Chair
Beijing Society of Pharmacology, Quantitative Pharmacology Professional Committee, Director
AWARDS AND CERTIFICATES
Pioneering and Excellence Award" from the Beijing Association for Science and Technology (2025)
“Fifth National Outstanding Teaching Case Award for Professional Degree in Pharmacy" from the National Steering Committee for Graduate Education of Professional Degree in Pharmacy (2021)
Third Prize, China Medical Science and Technology Award, Clinical Research and Promotion of Minimally Invasive Peripheral Tissue Pathology in the Diagnosis of Rare Neurological Diseases, Rank: 9th out of 11 participants (2020)
Major Project Organization Award, Peking University Health Science Center (2019)
Third Prize, Huaxia Medical Science and Technology Award, Establishment of a Pharmacogenomics Technology Platform for New Drug Clinical Trials, Rank: 4th out of 8 participants (2013)
Second Prize, Chinese Pharmaceutical Association Science and Technology Award, Establishment of a Pharmacogenomics Technology Platform for New Drug Clinical Trials, Rank: 3rd out of 4 participants (2012)
Outstanding Young Pharmacist Award, Inaugural China Hospital Pharmacy Award (2009)
REPRESENTATIVE PUBLICATIONS
1.Dan-Yun Ruan , Hao-Xiang Wu, Su-Xia Luo, Wen-Wen Huang ,Xin-Jun Liang, Zuo-Xing Niu, Qi Dang, Hong-Li Li, Zhan-Yu Pan, Hong-Xia Lu, Yan-Qiao Zhang, Xing-Ya Li, Xiu-Ying Xiao , Shi-Rong Cai , Yu-Gang Dong , Jian Zhang , Zhou Li , Hai-Tao Lan, Xin Wang, Ying Zhou, Lian Liu, He-Li Liu, Ping-Sheng Xu, Ai-Li Suo, Rui-Nuo Jia, Yong-Qiang Li, Xiao-Dong Peng, Si-Chen Wang , Ai-Ai Yu, Jie Xie, Miao-Zhen Qiu,*, Rui-Hua Xu*，The antibody-drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial; Nature Medicine (JCRQ1, IF=58.7)
2.Ting Yang, Chaoyang Chen, Lingyue Ma, Ying Zhou*. Association of aggression and anti-seizure medications in pediatric patients: Disproportionality analysis using the FDA adverse event reporting system; European Journal of Pharmacology (JCRQ1, IF=4.7)
3.Lili Lei, Junling Zhang, Ran Wei, Bingqi Dong, Xin Wang*,Ying Zhou*.Deciphering the Dual Role of Autophagy in Gastric Cancer and Gastroesophageal Junction Cancer: From Tumor Suppression to Cancer Progression; Discover Oncology (JCRQ2, IF=2.8)
4.Zhiqi Zhang, Zhuo Zhang, Qianxin Liu, Yan Zhang, Peng Jia, Lan Mi, Rui Lian, Fei Chen, Xiaocong Pang, Ying Zhou*. The impact of comprehensive pharmaceutical care on medication safety in gynecologic oncology chemotherapy patients. Exploratory Research in Clinical And Social Pharmacy（JCRQ3，IF=1.8）
5.Zhuo Zhang, Jiao Yu, Zhiqi Zhang, Qianxin Liu, Xiaocong Pang, Ying Zhou*. The Safety of Cadonilimab: A Systematic Review and Single-Arm Meta-Analysis, Cancer Medicine （JCRQ2，IF=3.1）
6.Lili Lei, Junling Zhang, Ran Wei, Bingqi Dong, Xin Wang*,Ying Zhou*. Deciphering the Dual Role of Autophagy in Gastric Cancer and Gastroesophageal Junction Cancer: From Tumor Suppression to Cancer Progression; Discover Oncology (JCRQ2,IF=2.8)
7.Zhigang Li, Lixin Du, Binghua Du, Zia Ullah, Yinghe Zhang, Yanyang Tu*, Ying Zhou*,Bing Guo*. Inorganic and hybrid nanomaterials for NIR-II fluorescence imaging-guided therapy of Glioblastoma and perspectives. Theranostics 2025;15(12): 5616-5665. (Q1,IF=12.4)
PATENT AND SOFTWARE COPYRIGHT
1.Fusion Protein Containing Membrane-Type RGD and Immune Cells Expressing Same, and Uses Thereof; Rong Zhuona, Pang Xiaocong, Zhou Ying, Teng Xia, Xiao Bofan, Wang Zhe, Wang Wenyi, Liu Hongjin; Application Number: 2024111423766
2.Entity Relation Joint Extraction Method Based on Bidirectional Tree Annotation; Yang Li, Wang Ping, Zhou Ying, Zheng Xizi, Chen Chaoyang, Luo Xukun; Patent Number: ZL 2023 1 1022054.3; Application Date: August 15, 2023; Grant Publication Number: CN 116757190 B; Grant Date: October 20, 2023
3.Machine Learning-Based AKI Risk Factor Analysis System; Yang Li, Zhou Ying, Zheng Xizi, Xu Damin, Ma Lingyun, Zhao Simiao; Software Copyright Registration Number: 2024SR0142962; Registration Date: January 22, 2024; Status: Unpublished